Gilead Sciences (United States) - Academic Profile

Publications

View All

Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV

Timothy P. Sheahan , Amy Sims , Sarah R. Leist +16 more

2020 Nature Communications 1785 citations

Spike mutation D614G alters SARS-CoV-2 fitness

Jessica A. Plante , Yang Liu , Jianying Liu +19 more

2020 Nature 1728 citations

Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease

Maria L. Agostini , Erica L. Andres , Amy Sims +14 more

ABSTRACT Emerging coronaviruses (CoVs) cause severe disease in humans, but no approved therapeutics are available. The CoV nsp14 exoribonuclease (ExoN) has complicated developme...

2018 mBio 1493 citations

ComBat-seq: batch effect adjustment for RNA-seq count data

Yuqing Zhang , Giovanni Parmigiani , W. Evan Johnson

Abstract The benefit of integrating batches of genomic data to increase statistical power is often hindered by batch effects, or unwanted variation in data caused by differences...

2020 NAR Genomics and Bioinformatics 1486 citations

Affiliated Researchers

Institution Info

Type: company
Country: US
Publications: 4
Citations: 6,492

External Links

Identifiers

ROR: https://ror.org/056546b03